Searched for
GLOBAL HEALTHCARE COMPANY
Reliance AGM 2026 Key Takeaways: Jio IPO, AI, satellite connectivity, JioTeleFrame & more; 10 biggest announcements from Ambani's vision for the futureReliance AGM 2026 Key Takeaways: Reliance Industries unveiled ambitious plans at its AGM 2026, including the approval of Jio Platforms' IPO...- L’Oréal adds Innovist to cart; HealthQuad's new fundHappy Friday! Personal care giant L’Oreal has acquired a majority stake in Innovist in India’s biggest D2C deal. This and more in today’s E...
- HealthQuad raises Rs 550 crore, eyes Rs 1,700 crore fundHealthQuad has secured Rs 550 crore for its third fund. The venture capital firm aims to raise Rs 1,700 crore to back early-growth companie...
- Silicon Valley chiefs discuss gigawatts & guardrails at G7Here’s everything you need to know about what was discussed at Wednesday’s working lunch among tech executives and global leaders.
- KKR eyes at least $1 billion stake in Medicover's India hospital arm, source saysGlobal investment firm KKR is in advanced discussions to acquire a significant stake in Medicover's Indian hospital operations. The deal is...
- Italian digital service company Engineering sells two units to AccentureEngineering, a prominent player in Italy's digital services landscape, is parting ways with its Alfahealth and Industries eXcellence units,...
- India among Asia-Pacific's most AI-ready healthcare markets as demand for coordinated care rises: BainIndia is emerging as one of the most AI-ready healthcare markets in the Asia-Pacific region, with a growing number of consumers using gener...
- Financials in a sweet spot, defence remains a structural bet: Dharmesh KantFinancial stocks are set to lead a market rally through June and July. Experts see banks and financial institutions benefiting from strong ...
- Cloudnine's 25% stake sale attracts top global PE firmsLeading global private equity firms are in the running to acquire a substantial minority stake in Cloudnine, India's premier maternity and ...
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
- Falling crude, stronger rupee could boost earnings outlook for India: Deepak ShenoyIndian stocks are poised for a favorable period. Falling crude oil prices and a strengthening rupee offer support. Macroeconomic conditions...
- Light at the end of the tunnel? Gautam Shah sees Nifty eyeing 25,500, bets on smallcaps, pharma and Adani stocksIndian equities are nearing a crucial turning point, with market veteran Gautam Shah suggesting a shift in focus beyond benchmark indices. ...
- The old health insurance model sees hospitalisation as an inconvenience, says Narayana Health's Viren Prasad Shetty; bets on managed care modelIt has been close to two years since Narayana Health’s wholly owned subsidiary, Narayana Health Insurance—which has adopted a ‘managed heal...
- Sudip Bandyopadhyay bets on pharma, metals and select cyclicals as geopolitical risks easeEasing West Asia tensions boost global markets, prompting investors to reassess opportunities. Market veteran Sudip Bandyopadhyay favors ph...
- Indian staffing cos step up global reach to diversify revenuesIndian staffing companies are actively expanding their global reach. They are tapping into international talent shortages across sectors li...
- PL Capital cuts Nifty target to 26,449, lists 16 high conviction stock picksAmidst global market turmoil from the Iran-US war and El Nino, PL Capital lowered its Nifty 50 target to 26,449. The brokerage anticipates ...
- India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...
- Haleon to invest Rs 2,000 crore to set up first India plantHaleon is investing Rs 2,000 crore to build its first manufacturing plant in Pithampur, India. This move sharpens its focus on India, a fas...
Load More
